ClinicalTrials.govpublic full text
Autologous T Cells With or Without Cyclophosphamide and Fludarabine in Treating Patients With Recurrent or Persistent Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer (Fludarabine Treatment Closed as of 12/01/2009)
fallopian tube cancer, ovarian cancer, primary peritoneal cavity cancer, recurrent ovarian epithelial cancer, stage iv ovarian epithelial cancer, recurrent primary peritoneal cavity cancer, stage iiia primary peritoneal cavity cancer, stage iiib primary peritoneal cavity cancer, stage iiic primary peritoneal cavity cancer, stage iv primary peritoneal cavity cancer, recurrent fallopian tube cancer, stage iiia fallopian tube cancer
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 890340
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.